We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.87%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.14B
AUM Growth
+$62.6M
Cap. Flow
-$68.5M
Cap. Flow %
-6%
Top 10 Hldgs %
20.56%
Holding
206
New
27
Increased
44
Reduced
47
Closed
29

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$19M
2
AXSM icon
Axsome Therapeutics
AXSM
+$12M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.2M
4
CHX
ChampionX
CHX
+$11M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$10.5M

Top Sells

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$15.9M
2
UTHR icon
United Therapeutics
UTHR
+$14.3M
3
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$13.4M
4
STAA icon
STAAR Surgical
STAA
+$11.7M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.14%
2 Technology 14.06%
3 Industrials 9.62%
4 Energy 8.22%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGF
176
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
– –
-3,399
Closed -$264K
SQSP
177
DELISTED
Squarespace, Inc.
SQSP
– –
-27,203
Closed -$581K
DICE
178
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-97,838
Closed -$1.98M
SWCH
179
DELISTED
Switch, Inc. Class A Common Stock
SWCH
– –
-62,954
Closed -$2.12M
CLR
180
DELISTED
CONTINENTAL RESOURCES INC.
CLR
– –
-44,687
Closed -$2.99M
4 5 6 7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Nicholas Investment Partners held 206 positions worth $1.14B, up 5.8% from $1.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $68.5M in Q4 2022, closing 29 positions and reducing 47 holdings. Its most notable exit was SpringWorks Therapeutics, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 44% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Lantheus worth $15.7M.

  • Nicholas Investment Partners's largest Q4 2022 buy was Lantheus: 308,295 shares worth $15.7M.
  • Nicholas Investment Partners added most to Wintrust Financial in Q4 2022, an estimated $5.83M increase.
  • Nicholas Investment Partners's biggest Q4 2022 reduction was Prometheus Biosciences, Inc. Common Stock, cutting an estimated $13.4M.
  • Nicholas Investment Partners fully exited SpringWorks Therapeutics in Q4 2022, selling an estimated $15.9M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.14B portfolio in Q4 2022.
  • Nicholas Investment Partners opened 27 new positions and closed 29 in Q4 2022.
  • Nicholas Investment Partners's portfolio value rose 5.8% quarter-over-quarter to $1.14B.

Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.